The authors showed that tumor infiltration of neutrophils was abrogated in Il1b−/− mice, which resulted in loss of immunosuppression and restoration of anti-tumor immunity during treatment with antiangiogenic agents targeting VEGF. This evidence concerns the gene IL1B and neoplasm.